- Home
- ACXP vs SURG Comparison
ACXP vs SURG Comparison
Compare ACXP & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- SURG
- Stock Information
- Founded
- ACXP 2017
- SURG 2006
- Country
- ACXP United States
- SURG United States
- Employees
- ACXP N/A
- SURG N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- SURG Advertising
- Sector
- ACXP Health Care
- SURG Consumer Discretionary
- Exchange
- ACXP Nasdaq
- SURG Nasdaq
- Market Cap
- ACXP 8.4M
- SURG 56.5M
- IPO Year
- ACXP 2021
- SURG N/A
- Fundamental
- Price
- ACXP $0.49
- SURG $3.24
- Analyst Decision
- ACXP Strong Buy
- SURG Strong Buy
- Analyst Count
- ACXP 2
- SURG 1
- Target Price
- ACXP $10.00
- SURG $9.00
- AVG Volume (30 Days)
- ACXP 18.6M
- SURG 106.8K
- Earning Date
- ACXP 08-08-2025
- SURG 08-12-2025
- Dividend Yield
- ACXP N/A
- SURG N/A
- EPS Growth
- ACXP N/A
- SURG N/A
- EPS
- ACXP N/A
- SURG N/A
- Revenue
- ACXP N/A
- SURG $40,029,467.00
- Revenue This Year
- ACXP N/A
- SURG $57.76
- Revenue Next Year
- ACXP N/A
- SURG $112.61
- P/E Ratio
- ACXP N/A
- SURG N/A
- Revenue Growth
- ACXP N/A
- SURG N/A
- 52 Week Low
- ACXP $0.30
- SURG $1.05
- 52 Week High
- ACXP $3.33
- SURG $3.47
- Technical
- Relative Strength Index (RSI)
- ACXP 51.70
- SURG 61.40
- Support Level
- ACXP $0.46
- SURG $2.86
- Resistance Level
- ACXP $0.56
- SURG $3.31
- Average True Range (ATR)
- ACXP 0.10
- SURG 0.24
- MACD
- ACXP -0.01
- SURG 0.04
- Stochastic Oscillator
- ACXP 25.55
- SURG 80.49
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.